Early prediction keys for COVID-19 cases progression: A meta-analysis
Author(s) -
Mostafa M. Khodeir,
Hassan A. Shabana,
Abdullah S. Alkhamiss,
Zafar Rasheed,
Mansour Alsoghair,
Suliman A. Alsagaby,
Muhammad Inam Khan,
Nelson Fernández,
Waleed Al Abdulmonem
Publication year - 2021
Publication title -
journal of infection and public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.983
H-Index - 35
eISSN - 1876-035X
pISSN - 1876-0341
DOI - 10.1016/j.jiph.2021.03.001
Subject(s) - medicine , meta analysis , pandemic , covid-19 , disease , copd , diabetes mellitus , creatinine , endocrinology , infectious disease (medical specialty)
BACKGROUNDː: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), within few months of being declared as a global pandemic by WHO, the number of confirmed cases has been over 75 million and over 1.6 million deaths since the start of the Pandemic and still counting, there is no consensus on factors that predict COVID-19 case progression despite the diversity of studies that reported sporadic laboratory predictive values predicting severe progression. We review different biomarkers to systematically analyzed these values to evaluate whether are they are correlated with the severity of COVID-19 disease and so their ability to be a predictor for progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom